Predictors of severity for postnatal cytomegalovirus infection in preterm infants and implications for treatment

References

• Britt W. Cytomegalovirus. In: Remington JS, Klein JO, Wilson CB, et al. editors. Infectious diseases in the fetus and newborn infant. Elsevier Saunders; Philadelphia, PA, USA: 2011. p. 706-55
   Google Scholar
• Stagno S, Reynolds DDW, Pass RFR, Alford CAC. Breast Milk and the Risk of Cytomegalovirus Infection. N Engl J Med 1980;302:1073-6
   PubMed Web of Science ®Google Scholar
• Kaye S, Miles D, Antoine P, et al. Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia. J Infect Dis 2008;197(9):1307-14
   PubMedGoogle Scholar
• Dworsky M, Yow M, Stagno S, et al. Cytomegalovirus Infection of Breast Milk and Transmission in Infancy. Pediatrics 1983;72:295-9
   PubMed Web of Science ®Google Scholar
• Peckham CS, Johnson C, Ades A, et al. Early acquisition of cytomegalovirus infection. Arch Dis Child 1987;62(8):780-5
   PubMedGoogle Scholar
• Kurath S, Halwachs-Baumann G, Müller W, Resch B. Transmission of cytomegalovirus via breast milk to the prematurely born infant: a systematic review. Clin Microbiol Infec 2010;16(8):1172-8
   PubMedGoogle Scholar
• Stagno S, Pass R, Dworsky M, Alford C. Congenital and Perinatal Infections. Semin Perinatol 1983;7(1):31-42
   PubMedGoogle Scholar
• Hamprecht K, Maschmann J, Vochem M, et al. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001;357:513-18
   PubMed Web of Science ®Google Scholar
• Lanzieri TM, Dollard SC, Josephson CD, et al. Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics 2013;131(6):e1937-45
   Web of Science ®Google Scholar
• Hamprecht K, Maschmann J, Jahn G, et al. Cytomegalovirus transmission to preterm infants during lactation. J Clin Virol 2008;41(3):198-205
   PubMedGoogle Scholar
• Luck S, Sharland M. Postnatal cytomegalovirus: innocent bystander or hidden problem? Arch Dis Child Fetal Neonatal 2009;94(1):F58-64
   Web of Science ®Google Scholar
• Reynolds D, Stagno S, Hosty T, et al. Maternal Cytomegalovirus Excretion and Perinatal Infection. N Engl J Med 1973;289(1):1-5
   PubMed Web of Science ®Google Scholar
• Vochem M, Hamprecht K, Jahn G, Speer CP. Transmission of cytomegalovirus to preterm infants through breast milk. Pediatr Infect Dis J 1998;17(1):53-8
   PubMedGoogle Scholar
• Maschmann J, Hamprecht K, Dietz K, et al. Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clin Infect Dis 2001;33(12):1998-2003
   PubMedGoogle Scholar
• Mussi-Pinhata MM, Yamamoto AY, do Carmo Rego MA, et al. Perinatal or early-postnatal cytomegalovirus infection in preterm infants under 34 weeks gestation born to CMV-seropositive mothers within a high-seroprevalence population. J Pediatr 2004;145(5):685-8
   PubMed Web of Science ®Google Scholar
• Miron D, Brosilow S, Felszer K, et al. Incidence and clinical manifestations of breast milk-acquired Cytomegalovirus infection in low birth weight infants. J Perinatol 2005;25(5):299-303
   PubMedGoogle Scholar
• Numazaki K. Human cytomegalovirus infection of breast milk. FEMS Immunol Med Mic 1997;18:91-8
   PubMedGoogle Scholar
• Jim WTT, Shu CHH, Chiu NCC, et al. High cytomegalovirus load and prolonged virus excretion in breast milk increase risk for viral acquisition by very low birth weight infants. Pediatr Infect Dis J 2009;28(10):891-4
   PubMedGoogle Scholar
• Jackson SE, Mason GM, Wills MR. Human cytomegalovirus immunity and immune evasion. Virus Res 2011;157(2):151-60
   PubMed Web of Science ®Google Scholar
• Sabbaj S, Ghosh MK, Edwards BH, et al. Breast milk-derived antigen-specific CD8+ T cells: an extralymphoid effector memory cell population in humans. J Immunol 2005;174(5):2951-6
   PubMedGoogle Scholar
• Wakabayashi H, Mizuno K, Kohda C, et al. Low HCMV DNA copies can establish infection and result in significant symptoms in extremely preterm infants: a prospective study. Am J Perinatol 2012;1(212):1-6
   Google Scholar
• Hamprecht K, Goelz R, Maschmann J. Breast milk and cytomegalovirus infection in preterm infants. Early Hum Dev 2005;81(12):989-96
   PubMedGoogle Scholar
• Mussi-Pinhata MM, Pinto PCG, Yamamoto AY, et al. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates. J Med Virol 2003;69(2):232-9
   PubMedGoogle Scholar
• Hamele M, Flanagan R, Loomis CA, et al. Severe morbidity and mortality with breast milk associated cytomegalovirus infection. Pediatr Infect Dis J 2010;29(1):84-6
   PubMedGoogle Scholar
• Maschmann J, Hamprecht K, Weissbrich B, et al. Freeze-thawing of breast milk does not prevent cytomegalovirus transmission to a preterm infant. Arch Dis Child Fetal Neonatal Ed 2006;91(4):F288-90
   Google Scholar
• Cheong JLY, Cowan FM, Modi N. Gastrointestinal manifestations of postnatal cytomegalovirus infection in infants admitted to a neonatal intensive care unit over a five year period. Arch Dis Child Fetal Neonatal Ed 2004;89(4):F367-9
   Google Scholar
• Nijman J, van Zanten GA, de Waard AM, et al. Hearing in preterm infants with postnatally acquired cytomegalovirus infection. Pediatr Infect Dis J 2012;31(10):1082-4
   PubMedGoogle Scholar
• Neuberger P, Hamprecht K, Vochem M, et al. Case-control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants. J Pediatr 2006;148(3):326-31
   PubMedGoogle Scholar
• Turner K, Lee H, Boppana S, et al. Incidence and impact of CMV infection in very low birth weight infants. Pediatrics 2014;133(3):1-7
   PubMedGoogle Scholar
• Nijman J, de Vries LS, Koopman-Esseboom C, et al. Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings. Arch Dis Child Fetal Neonatal 2012;97:F259-63
   Google Scholar
• Amir J, Schwarz M, Levy I, et al. Is lenticulostriated vasculopathy a sign of central nervous system insult in infants with congenital CMV infection? Arch Dis Child 2011;96(9):846-50
   PubMed Web of Science ®Google Scholar
• Streblow DN, Dumortier J, Moses A V, et al. Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr Top Microbiol Immunol 2008;325:397-415
   PubMed Web of Science ®Google Scholar
• Nijman J, Gunkel J, de Vries LS, et al. Reduced occipital fractional anisotropy on cerebral diffusion tensor imaging in preterm infants with postnatally acquired cytomegalovirus infection. Neonatology 2013;104(2):143-50
   PubMedGoogle Scholar
• Dorn M, Lidzba K, Bevot A, et al. Long-term neurobiological consequences of early postnatal hCMV-infection in former preterms: a functional MRI study. Hum Brain Mapp 2014;35(6):2594-606
   PubMedGoogle Scholar
• Vollmer B, Seibold-Weiger K, Schmitz-Salue C, et al. Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants. Pediatr Infect Dis J 2004;23(4):322-7
   PubMed Web of Science ®Google Scholar
• Baerts W, van Straaten HLM. Auditory neuropathy associated with postnatally acquired cytomegalovirus infection in a very preterm infant. BMJ Case Rep 2010; doi; 10.1136/bcr.01.2010.2689
   PubMedGoogle Scholar
• Mehler K, Oberthuer A, Lang-Roth R, Kribs A. High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22-24 weeks’ gestation after transmission via breast milk. Neonatology 2014;105(1):27-32
   PubMedGoogle Scholar
• Bevot A, Hamprecht K, Krägeloh-Mann I, et al. Long-term outcome in preterm children with human cytomegalovirus infection transmitted via breast milk. Acta Paediatr 2011;101(4):e167-72
   Google Scholar
• Paryani SG, Yeager AS, Hosford-Dunn H, et al. Sequelae of acquired cytomegalovirus infection in premature and sick term infants. J Pediatr 1985;107(3):451-6
   PubMedGoogle Scholar
• Jim WT, Shu CH, Chiu NC, et al. Transmission of cytomegalovirus from mothers to preterm infants by breast milk. Pediatr Infect Dis J 2004;23(9):848-51
   PubMedGoogle Scholar
• Goelz R, Meisner C, Bevot A, et al. Long-term cognitive and neurological outcome of preterm infants with postnatally acquired CMV infection through breast milk. Arch Dis Child Fetal Neonatal Ed 2013;98(5):F430-3
   PubMed Web of Science ®Google Scholar
• Doctor S, Friedman S, Dunn M, et al. Cytomegalovirus transmission to extremely low-birthweight infants through breast milk. Acta Paediatr 2005;94(1):53-8
   PubMedGoogle Scholar
• Buxmann H, Miljak A, Fischer D, et al. Incidence and clinical outcome of cytomegalovirus transmission via breast milk in preterm infants </=31 weeks. Acta Paediatr 2009;98(2):270-6
   PubMedGoogle Scholar
• Nijman J, van Loon A, Krediet T, Verboon-Maciolek M. Maternal and neonatal anti-cytomegalovirus IgG level and risk of postnatal cytomegalovirus transmission in preterm infants. J Med Virol 2013;85:689-95
   PubMedGoogle Scholar
• Muller W, Jones C, Koelle D. Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn. Curr Immunol Rev 2010;6(1):38-55
   PubMedGoogle Scholar
• Schleiss MR. Cytomegalovirus in the neonate: immune correlates of infection and protection. Clin Dev Immunol 2013;2013:501801
   PubMedGoogle Scholar
• Sharma AA, Jen R, Butler A, Lavoie PM. The developing human preterm neonatal immune system: a case for more research in this area. Clin Immunol 2012;145(1):61-8
   PubMed Web of Science ®Google Scholar
• Capretti MG, Lanari M, Lazzarotto T, et al. Very low birth weight infants born to cytomegalovirus-seropositive mothers fed with their mother’s milk: a prospective study. J Pediatr 2009;154(6):842-8
   PubMedGoogle Scholar
• Gunkel J, Wolfs T, Nijman J, et al. Urine is superior to saliva when screening for postnatal CMV infections in preterm infants. J Clin Virol 2014;61(1):61-4
   PubMedGoogle Scholar
• Nijman J, van Loon AM, de Vries LS, et al. Urine viral load and correlation with disease severity in infants with congenital or postnatal cytomegalovirus infection. J Clin Virol 2012;54(2):121-4
   PubMedGoogle Scholar
• Pignatelli S, Lazzarotto T, Gatto MR, et al. Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae. Clin Infect Dis 2010;51(1):33-41
   PubMed Web of Science ®Google Scholar
• Stranska R, Schuurman R, Toet M, et al. Application of UL144 molecular typing to determine epidemiology of cytomegalovirus infections in preterm infants. J Clin Microbiol 2006;44(3):1108-10
   PubMedGoogle Scholar
• Arav-Boger R, Willoughby RE, Pass RF, et al. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis 2002;186(8):1057-64
   PubMed Web of Science ®Google Scholar
• Yan H, Koyano S, Inami Y, et al. Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. Arch Virol 2008;153(4):667-74
   PubMedGoogle Scholar
• Paradowska E, Studzińska M, Nowakowska D, et al. Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections. Eur J Clin Microbiol Infect Dis 2012;31(7):1335-45
   PubMedGoogle Scholar
• Paradowska E, Jabłońska A, Studzińska M, et al. Distribution of cytomegalovirus gN variants and associated clinical sequelae in infants. J Clin Virol 2013;58(1):271-5
   PubMed Web of Science ®Google Scholar
• Strunk T, Currie A, Richmond P, et al. Innate immunity in human newborn infants: prematurity means more than immaturity. J Matern Fetal Neonatal Med 2011;24(1):25-31
   PubMed Web of Science ®Google Scholar
• Wujcicka W, Wilczyński J, Nowakowska D. Alterations in TLRs as new molecular markers of congenital infections with human cytomegalovirus? Pathog Dis 2014;70(1):3-16
   PubMed Web of Science ®Google Scholar
• Taniguchi R, Koyano S, Suzutani T, et al. Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV disease. Int J Infect Dis 2013;17(12):e1092-7
   PubMed Web of Science ®Google Scholar
• Arav-Boger R, Wojcik GL, Duggal P, et al. Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine. BMC Res Notes 2012;5(1):140
   PubMedGoogle Scholar
• Johnston M, Landers S, Noble L, et al. Breastfeeding and the use of human milk. Pediatrics 2012;129(3):e827-41
   Google Scholar
• Buxmann H, Falk M, Goelz R, et al. Feeding of very low birth weight infants born to HCMV-seropositive mothers in Germany, Austria and Switzerland. Acta Paediatr 2010;99(12):1819-23
   PubMedGoogle Scholar
• Hayashi S, Kimura H, Oshiro M, et al. Transmission of cytomegalovirus via breast milk in extremely premature infants. J Perinatol 2011;31:440-5
   PubMed Web of Science ®Google Scholar
• Hamprecht K, Maschmann J, Müller D, et al. Cytomegalovirus (CMV) inactivation in breast milk: reassessment of pasteurization and freeze-thawing. Pediatr Res 2004;56(4):529-35
   PubMed Web of Science ®Google Scholar
• Terpstra FG, Rechtman DJ, Lee ML, et al. Antimicrobial and antiviral effect of high-temperature short-time (HTST) pasteurization applied to human milk. Breastfeed Med 2007;2(1):27-33
   PubMedGoogle Scholar
• Goelz R, Hihn E, Hamprecht K, et al. Effects of different CMV-heat-inactivation-methods on growth factors in human breast milk. Pediatr Res 2009;65(4):458-61
   PubMedGoogle Scholar
• García-Lara NR, Vieco DE, De la Cruz-Bértolo J, et al. Effect of Holder pasteurization and frozen storage on macronutrients and energy content of breast milk. J Pediatr Gastroenterol Nutr 2013;57(3):377-82
   PubMed Web of Science ®Google Scholar
• Sharland M, Luck S, Griffiths P, Cotton M. Antiviral therapy of CMV disease in children. Adv Exp Med Biol 2011;697:243-60
   PubMed Web of Science ®Google Scholar
• Kimberlin DDW, Lin C-YC, Sánchez PPJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003;143(1):16-25
   PubMed Web of Science ®Google Scholar
• Fischer C, Meylan P, Bickle Graz M, et al. Severe postnatally acquired cytomegalovirus infection presenting with colitis, pneumonitis and sepsis-like syndrome in an extremely low birthweight infant. Neonatology 2010;97(4):339-45
   PubMedGoogle Scholar
• Oliver SE, Cloud GA, Sánchez PJ, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 2009;46(Suppl 4):S22-6
   PubMed Web of Science ®Google Scholar
• Snydman D, Werner B. Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates. Pediatr Infect Dis J 1995;14(1):34-40
   PubMedGoogle Scholar
• Takahashi R, Tagawa M, Sanjo M, et al. Severe postnatal cytomegalovirus infection in a very premature infant. Neonatology 2007;92(4):236-9
   PubMedGoogle Scholar
• Gerna G, Sarasini A, Patrone M, et al. Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J Gen Virol 2008;89(Pt 4):853-65
   PubMedGoogle Scholar
• Fouts AE, Chan P, Stephan JP, et al. Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin. J Virol 2012;86(13):7444-7
   PubMed Web of Science ®Google Scholar
• Tengsupakul S, Birge ND, Bendel CM, et al. Asymptomatic DNAemia heralds CMV-associated NEC: case report, review, and rationale for preemption. Pediatrics 2013;132(5):e1428-34
   Google Scholar